
Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, explores potential international technology that may transform the injectable space.

Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, explores potential international technology that may transform the injectable space.

The top articles in recent literature offer a roadmap for new directions in dermatology practice.

Theodore Rosen, MD, presents the best therapies for central centrifugal cicatricial alopecia and fontal fibrosing alopecia.

Maui Derm NP+PA Summer 2022 Conference begins today in Colorado Springs, Colorado, offering a selection of in-person and virtual educational workshops and presentations.

Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, discusses what to expect from Maui Derm NP+PA Summer 2022 Conference.

Barbara McElroy, MSN, CRNI, VA-BC, shares her expert knowledge on placing IVs and treating patients to help health care workers optimize this procedure at the 2022 National Infusion Center Association Annual Conference.

Lindsey Savickas, RN, BSN, and COO at Infusion Associates, explains how infusion centers can support researchers in the dermatology space in discovering more effective treatments.

Barbara McElroy, MSN, CRNI, VA-BC, explains the responsibility a nurse has to their patient and how the Nurse Practicing Act needs to be more well-known.

Infusion centers are very much affected by legislative action on drugs. An expert offers insights into how best to navigate the situation.

Knowing advocacy types and how to get patients involved in advocating for themselves is a key topic in the medical world as drug access can become a confusing issue to tackle. A group of panelists at the 2022 NICA Annual Conference explained how clinicians can help their patients.

Robert Dracker, MD, MHA, MBA, CPI, medical director of Summerwood Pediatrics & Infusacare Medical Services, sits down to discuss why choosing an infusion center with pediatric experience will improve treatment outcomes.

Growth in new biologic treatments for widespread cutaneous disease along with innovation in medications for rare conditions such as generalized pustular psoriasis have moved infusion therapy from a nice-to-know to a need-to-know point on dermatologists’ continuing learning curve. The National Infusion Center Association provides answers to commonly asked questions about biologics in an informative presentation at the end of this article.

At the 2022 National Infusion Center Association Annual Conference, Kelly Gordon, PharmD, answered why diagnosing GPP is so difficult and what to look for to optimize patient care.

Robert Dracker, MD, MHA, MBA, CPI discussed considerations and developmentally appropriate interventions to promote high quality, patient-centered pediatric infusion care in a presentation at the 2022 National Infusion Center Association Annual Conference.

At the SDPA 2022 Annual Summer Dermatology Conference, a session on both common and rare dermatological disorders.

Lindsey Savickas, RN, BSN, and COO at Infusion Associates, explains how infusion centers and dermatologists are going to work together more as medications become more advanced.

Brian Nyquist, MPH, the CEO of the National Infusion Center Association (NICA), talks on the engaging sessions happening this weekend at the NICA conference and its growing importance to the dermatology community.

The 2022 National Infusion Center Association Conference will begin with several sessions focused on advocacy, clinical, management, and operations topics.

The Society for Dermatology Physician Assistants (SDPA) begins its summer dermatology conference today, which will continue until Sunday, June 19, 2022, in Austin, Texas. Follow along for coverage.

Joshua Zeichner, MD, discusses how important it is to treat acne properly and gives a tip about moisturizers and topical retinoids.

Speaking at the 2022 Fall Clinical Dermatology Conference for PAs & NPs, Joshua Zeichner, MD, cut through marketing hype and misperceptions of patients to assess products that bridge cosmetics and medicine.

Education, honesty, and communication skills are key for both patient and dermatologist when it comes to creating treatment regimens.

James Q. Del Rosso, DO, highlights different rosacea treatment options in his session at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Darrell S. Rigel, MD, MS, FAAD, answers the question of what is up coming in the world of dermatology in the way of precision medicine.

In a session for the 2022 Fall Clinical Dermatology Conference for PAs & NPs, held June 3 to 5, in Scottsdale, Arizona, James Q. Del Rosso, DO, delves into new knowledge on the characteristics of this challenging skin condition.

Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases (STDs) to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

In a video with Dermatology Times®, James Q. Del Rosso, DO, discusses his presentation “What’s News in the Medicine Chest” at the current 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Will drinking caffeinated coffee reduce skin cancer risk? Is gene expression profiling set to become mainstream testing for melanoma? See what Darrell S. Rigel, MD, MS, FAAD, has to say.

In a hard-hitting session from the 2022 Fall Clinical Dermatology Conference for PAs & NPs, April Armstrong, MD, MPH, dove into PAD technology and future innovations in psoriasis treatment.

A poster presented at the current 2022 Fall Clinical Dermatology Conference for PAs & NPs showed normalization of skin barrier function in patients with moderate to severe atopic dermatitis taking dupilumab, according to the investigators.